comparemela.com

Page 5 - Antigen Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Preliminary results

Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Preliminary results
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Why the Midlands are an undercapitalised region for growth businesses

New Products

Cytosections for Antibody Screening AMS Biotechnology (AMSBIO) has launched a comprehensive range of cytosections that offer a verified, reproducible, and renewable source of positive/negative controls where the expression of the target biomarker is confirmed for accuracy and specificity by an immunoassay. Researchers, antibody and assay developers, and immunohistochemistry (IHC) labs often have difficulty finding a reliable and verified source of positive/negative controls for their IHC experiments. AMSBIO s new cytosections range consists of high-quality FFPE sections of cell pellets of overexpressing targeted biomarkers. The expression of target biomarkers in these cytosections is carefully verified for accuracy and specificity using Western blot. Positive controls (cells transfected with the target protein) and negative controls (mock transfected cells) are available for genome-wide human and mouse genome targets. In addition to its standard range, AMSBIO also offers a custom cy

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.